Research Insights
Research Insights section focuses on the cutting-edge and breakthrough research that is happening all over the world. Laboratories across the globe are working hard to develop drugs and therapies for various diseases and research insights directly from them add tremendous value.
Machine learning and deep learning techniques to support clinical diagnosis of arboviral diseases: A systematic review
Neglected tropical diseases NTDs primarily affect the poorest populations often living in remote rural areas urban slums or conflict zones Arboviruses are a significant NTD category spread by mosquitoes Dengue Chikungunya and Zika are three arboviruses that affect a large proportion of the population in Latin and South America
High-throughput framework for genetic analyses of adverse drug reactions using electronic health records
Understanding the contribution of genetic variation to drug response can improve the delivery of precision medicine However genomewide association studies GWAS for drug response are uncommon and are often hindered by small sample sizes
Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cells
COVID vaccines based on the Spike protein of SARSCoV have been developed that appear to be largely successful in stopping infection However therapeutics that can help manage the disease are still required until immunity has been achieved globally
Bioinformatic analysis identifies potential key genes of epilepsy
Epilepsy is one of the most common brain disorders worldwide It is usually hard to be identified properly and a third of patients are drugresistant Genes related to the progression and prognosis of epilepsy are particularly needed to be identified
Virus-derived variation in diverse human genomes
Acquisition of genetic material from viruses by their hosts can generate interhost structural genome variation We developed computational tools enabling us to study virusderived structural variants SVs in populationscale whole genome sequencing WGS datasets and applied them to humans Although SVs had already been cataloged in these subjects
The landscape of antibody binding in SARS-CoV-2 infection
The search for potential antibodybased diagnostics vaccines and therapeutics for pandemic severe acute respiratory syndrome coronavirus SARSCoV has focused almost exclusively on the spike S and nucleocapsid N proteins Coronavirus membrane M ORFa and ORF proteins are humoral immunogens in other coronaviruses
The impact of age on genetic risk for common diseases
Inherited genetic variation contributes to individual risk for many complex diseases and is increasingly being used for predictive patient stratification Previous work has shown that genetic factors are not equally relevant to human traits across age and other contexts
Rare variants regulate expression of nearby individual genes in multiple tissues
The rapid decrease in sequencing cost has enabled genetic studies to discover rare variants associated with complex diseases and traits Once this association is identified the next step is to understand the genetic mechanism of rare variants on how the variants influence diseases Similar to the hypothesis of common variants
Bioinformatics prediction of differential miRNAs in non-small cell lung cancer
Nonsmall cell lung cancer NSCLC accounts for of all lung cancers The drug resistance of NSCLC has clinically increased This study aimed to screen miRNAs associated with NSCLC using bioinformatics analysis We hope that the screened miRNA can provide a research direction for the subsequent treatment
A patient-oriented research approach to assessing patients’ and primary care physicians’ opinions on trauma-informed care
To gather patients and primary care physicians PCP opinions on traumainformed Care TIC and to investigate the acceptability of recommendations developed by patient family and physician advisors
